On Friday, Transmedics Group Inc (NASDAQ: TMDX) was -4.16% drop from the session before settling in for the closing price of $79.34. A 52-week range for TMDX has been $67.77 – $177.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 95.07% over the past five years. When this article was written, the company’s average yearly earnings per share was at 228.09%. With a float of $32.44 million, this company’s outstanding shares have now reached $32.67 million.
Let’s look at the performance matrix of the company that is accounted for 584 employees. In terms of profitability, gross margin is 59.29%, operating margin of 7.84%, and the pretax margin is 8.14%.
Transmedics Group Inc (TMDX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Transmedics Group Inc stocks. The insider ownership of Transmedics Group Inc is 3.35%, while institutional ownership is 109.95%. The most recent insider transaction that took place on Nov 11 ’24, was worth 131,278. In this transaction Chief Commercial Officer of this company sold 1,458 shares at a rate of $90.04, taking the stock ownership to the 20,843 shares. Before that another transaction happened on Nov 05 ’24, when Company’s Director sold 6,750 for $83.55, making the entire transaction worth $563,994. This insider now owns 732 shares in total.
Transmedics Group Inc (TMDX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 228.09% per share during the next fiscal year.
Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators
You can see what Transmedics Group Inc (TMDX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.93, a number that is poised to hit 0.17 in the next quarter and is forecasted to reach 1.56 in one year’s time.
Technical Analysis of Transmedics Group Inc (TMDX)
Transmedics Group Inc (NASDAQ: TMDX) saw its 5-day average volume 1.94 million, a positive change from its year-to-date volume of 0.99 million. As of the previous 9 days, the stock’s Stochastic %D was 11.91%. Additionally, its Average True Range was 6.39.
During the past 100 days, Transmedics Group Inc’s (TMDX) raw stochastic average was set at 3.21%, which indicates a significant decrease from 12.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.92% in the past 14 days, which was lower than the 79.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $119.18, while its 200-day Moving Average is $122.17. Nevertheless, the first resistance level for the watch stands at $77.71 in the near term. At $79.38, the stock is likely to face the second major resistance level. The third major resistance level sits at $81.90. If the price goes on to break the first support level at $73.52, it is likely to go to the next support level at $71.01. The third support level lies at $69.34 if the price breaches the second support level.
Transmedics Group Inc (NASDAQ: TMDX) Key Stats
There are 33,562K outstanding shares of the company, which has a market capitalization of 2.45 billion. As of now, sales total 241,620 K while income totals -25,030 K. Its latest quarter income was 108,760 K while its last quarter net income were 4,220 K.
